Adenoviral delivery of B7–1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells
- 1 July 1998
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 5 (7) , 965-974
- https://doi.org/10.1038/sj.gt.3300672
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 0 references indexed in Scilit: